

SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
To donate by check, phone, or other method, see our More Ways to Give page.


Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.

Hannah Connor, Center for Biological Diversity, (202) 681-1676,
hconnor@biologicaldiversity.org
Jackie Filson, Food & Water Watch, (202) 683-2538, jfilson@fwwatch.org
Today, the Center for Biological Diversity and Food & Water Watch sent a formal notice of their intent to sue JBS USA and the JBS-Swift Beef Company for Clean Air Act violations at its Greeley Beef Plant.
The groups allege JBS-Swift Beef has violated the Clean Air Act by using a precarious method to dispose of wastewater without the mandated tracking of potential ozone pollution.
Today, the Center for Biological Diversity and Food & Water Watch sent a formal notice of their intent to sue JBS USA and the JBS-Swift Beef Company for Clean Air Act violations at its Greeley Beef Plant.
The groups allege JBS-Swift Beef has violated the Clean Air Act by using a precarious method to dispose of wastewater without the mandated tracking of potential ozone pollution.
JBS-Swift Beef's 2015 air permit requires the company conduct testing and sampling of salty wastewater generated during the processing of hides from slaughtered animals to ensure compliance of pollutant emissions limits. However, over the past four years, the company failed to conduct the mandated testing and has used an evaporator to manage and dispose of this wastewater since January 2019.
"As one of the world's biggest meat producers, JBS should be a leader in making sure its slaughter operations aren't polluting the region's air or water," said Hannah Connor, a senior attorney at the Center. "Colorado's communities and wildlife deserve better than chronic noncompliance with laws that are in place to protect the region's air quality, especially given the state's ongoing problem with controlling smog along the Front Range."
As a part of its beef slaughterhouse in Greeley, Colo., JBS-Swift Beef operates a rendering plant that breaks down animal byproducts such as blood, fats and animal hides. A brine-saltwater bath is used in that process to preserve the hides for sale. This rendering process generates an estimated 5.2 million gallons of salt-brine wastewater per year.
JBS-Swift Beef has used an evaporator to manage and dispose of this wastewater since January 2019. But the plant's Clean Air Act permit requires JBS-Swift Beef to conduct testing and sampling to address ozone pollution and confirm that the plant is not exceeding its permitted emissions limits for other pollutants, requirements with which the company has not complied.
"Salts can be harmful to aquatic ecosystems, but while reducing the briny wastewater discharged into Lone Tree Creek through the use of an evaporator system may have temporary benefits for water quality, it is unacceptable for JBS to simply violate the Clean Air Act in order to do so," said Tarah Heinzen, senior attorney with Food & Water Watch. "We expect JBS to comply with all of its pollution requirements, not to pick and choose among them."
Background
Determining whether the JBS wastewater disposal is contributing to ozone pollution is important because the company's rendering plant is located in a region that is failing to meet air-quality standards set by the U.S. Environmental Protection Agency due to high levels of ground-level ozone.
Smog threatens public health by worsening asthma attacks and increasing hospital visits; it can even kill people.
Smog also harms wildlife and ecosystems. The region's ponderosa pines are particularly sensitive to smog pollution, which can stunt growth and increase risks from disease, weather and insects. Ponderosa pine habitat in the region is critical for several species, including the threatened Mexican spotted owl.
Today's notice follows a lawsuit brought by the Center for Biological Diversity and Food & Water Watch earlier this year that challenges JBS USA and the JBS-Swift Beef Company's chronic Clean Water Act permit violations at its Lone Tree Wastewater Treatment Plant, also in Greeley.
The new notice gives JBS USA and the JBS-Swift Beef Company 60 days to resolve the violations. The Center for Biological Diversity and Food & Water Watch are represented in this action by counsel with the nonprofit legal advocacy organization Public Justice, as well as in-house counsel.
Food & Water Watch mobilizes regular people to build political power to move bold and uncompromised solutions to the most pressing food, water, and climate problems of our time. We work to protect people's health, communities, and democracy from the growing destructive power of the most powerful economic interests.
(202) 683-2500"Donald Trump and Republicans have left children and their families poorer and worse off in ways that will be felt for generations."
A report released Tuesday by Democrats on the Senate Finance Committee details how US President Donald Trump and Republicans in Congress are waging a multifront war on children by targeting healthcare programs, education, and nutrition assistance as part of their scorched-earth assault on the nation's safety net and redistribution of wealth to the very top.
"In just months, the Trump administration has gutted access to healthcare for millions of children, slashed funding for school meals and nutrition assistance, fired thousands of workers dedicated to advancing child welfare and protecting children, and unleashed policies that traumatize and harm immigrant families and LGBTQ+ youth," reads the report. "These actions are not isolated—they reflect a coordinated agenda that will leave a generation of children sicker, hungrier, and less safe."
As part of the sprawling budget reconciliation package that Trump signed into law over the summer, Republicans enacted the largest-ever cuts to Medicaid and the Supplemental Nutrition Assistance Program (SNAP), slashing more than $1 trillion combined from the two programs.
Roughly half of all kids in the US are covered by either Medicaid or the Children's Health Insurance Program, and around 40% of SNAP beneficiaries are children, meaning cuts to those programs will have far-reaching impacts on the nation's youth in the coming years.
"By making the largest cuts to healthcare and food assistance in the nation’s history, Donald Trump and Republicans have left children and their families poorer and worse off in ways that will be felt for generations," Sen. Ron Wyden (D-Ore.), the top Democrat on the Senate Finance Committee, said in a statement on Tuesday.
"By dismantling the very systems that safeguard children’s health and future, Trump and Republicans are condemning a generation to poorer health, deeper poverty, and diminished opportunity."
In addition to denouncing cuts to Medicaid and SNAP, the new report outlines how the Trump administration is imperiling mental health programs by canceling grants and other funding, harming children's education by throttling Head Start funds, and inflicting deadly cuts to programs that aid kids overseas—all while delivering massive tax cuts to the richest Americans and largest corporations.
"Trump’s cuts to healthcare access, food assistance, and education have stripped millions of kids of the care, nutrition, and protection they need to thrive," the report states. "By dismantling the very systems that safeguard children’s health and future, Trump and Republicans are condemning a generation to poorer health, deeper poverty, and diminished opportunity."
"Unless stopped," the report concludes, "Trump’s war on kids will leave lasting scars on millions of children and weaken the nation for decades to come."
"He’s not thinking about the democratization of Venezuela, let alone the narco-trafficking," said the Latin American leader. "In general, all of the wars of this century had to do with oil."
Colombian President Gustavo Petro said Tuesday that US President Donald Trump's central focus with his attacks and threats against Venezuela is the desire for the nation's vast oil reserves and little if anything to do with stopping illegal drug trafficking or improving the nation's democratic prospects under President Nicolas Maduro.
In an face-to-face interview with CNN's Isa Soeres, which the correspondent described as "fiery" at times, Petro explained that Venezuela's oil reserves, among the largest in the world, is "at the heart of the matter" when it comes to Trump's repeated extrajudicial killings in waters of the nation's coast this year and a broader military buildup that includes deployment of the USS Gerald R. Ford aircraft carrier group and mobilization of US Southern Command.
"What lies behind this," said Petro, "is the same thing behind the war in Ukraine... petroleum," noting the size and quality of Venezuela's reserves. "In general, all of the wars of this century had to do with oil."
If Trump were to get the upper hand, Petro suggested, the United States would get Venezuela's oil "almost for free," predicting that—"based on the evidence so far"—that the US will go to war over the resources.
Trump, said Petro, "is not thinking about the democratization of Venezuela, let alone the narco-trafficking," adding that Venezuela is not considered a major drug producer or transit point for most narcotics headed to the United States.
"You only have to look at the numbers," said Petro. "Only about 4 percent of Colombia's cocaine production... goes through Venezuela—a small margin—while most of it goes out through the Pacific Ocean."
As CNN notes, "Petro has been at odds with Trump since he returned to the White House. In the past year, the Colombian leader has harshly criticized the Trump administration’s immigration policies, its support for Israel and its military activity around Latin America."
In September, the US State Department under Trump had Petro's visa revoked following critical comments he made during the UN General Assembly in New York.
This week, the US designated a new group, the Cartel do Los Soles, as a terrorist organization, naming Maduro its de facto leader, a claim that experts say there is no evidence to support.
Asked by CNN if he assesses Maduro as a gang leader, dictator, or narcotrafficker, Petro said investigations in Colombia have never shown Maduro to be connected to the black market drug trade and that his country's data doesn't even show the existence of the alleged cartel designated this week by the Trump administration.
"The problem of Maduro," said Petro, "is lack of democracy and dialogue."
"Medicare drug price negotiation is about to deliver tangible lower costs to seniors in Medicare, unlike Trump’s ceremonial events with Big Pharma CEOs in the Oval Office," said one Democratic senator.
The Trump administration on Tuesday announced newly negotiated prices for more than a dozen prescription drugs covered by Medicare, an achievement made possible by a Biden-era law that has faced relentless attacks from the pharmaceutical industry, GOP lawmakers, and the Republican president.
The announcement marks the end of the second round of Medicare drug price negotiations required under the Inflation Reduction Act (IRA), a measure passed in 2022 without the support of a single Republican in Congress. Last year, House GOP leaders said the law was "disastrous" and decried what they called "the mandate from bureaucrats to artificially set prescription drug prices."
The new list contains 15 drugs, including the diabetes and weight loss medication Ozempic, the breast cancer drug Ibrance, and the prostate cancer drug Xtandi. The Centers for Medicare & Medicaid Services (CMS) estimated that if the new prices—which take effect in 2027—had been in effect last year, Medicare would have saved $12 billion.
President Donald Trump campaigned on rolling back the IRA, which for the first time allowed Medicare to negotiate drug prices directly with pharmaceutical companies. Since taking office, Trump has taken steps to weaken the law, including by signing a measure that will exempt certain high-priced drugs from Medicare negotiations—a multibillion-dollar handout to Big Pharma.
But in statements on Tuesday, Trump-appointed officials hailed the newly negotiated prices. Robert F. Kennedy Jr., secretary of the Health and Human Services Department, said the negotiation results stemmed from a Trump directive to "stop at nothing to lower healthcare costs for the American people."
CMS Administrator Mehmet Oz declared that the second round of negotiations was more successful than the first, which was held under the Biden administration. Experts said that claim is specious at best.
Democratic lawmakers were quick to highlight Republican opposition to the IRA, and continued attacks on the law, in response to the newly negotiated prices.
"Democrats took on Big Pharma by giving Medicare the power to negotiate on behalf of the tens of millions of seniors that want lower drug prices while every Republican voted against it,” said Sen. Ron Wyden (D-Ore.), the top Democrat on the Senate Finance Committee. “Today’s announcement is a result of that effort by Democrats to lower health costs for older Americans."
"Medicare drug price negotiation is about to deliver tangible lower costs to seniors in Medicare, unlike Trump’s ceremonial events with Big Pharma CEOs in the Oval Office," Wyden added. "Republicans neutered future Medicare drug price negotiations by adding delays and exemptions to some of the most expensive drugs, especially cancer drugs like Keytruda."
Tuesday's announcement came less than a week after the pharmaceutical industry suffered its 16th defeat in court as it continues its legal campaign against the Medicare price negotiations. The industry is also lobbying aggressively in support of legislation that would further weaken the IRA price-negotiation provisions.
"Drug corporations already secured a $9 billion giveaway from President Trump and congressional Republicans paid for by taxpayers and cancer patients through the Big Ugly Bill, and they are trying to go even further to delay and exempt price negotiations for more blockbuster drugs," said Steve Knievel, access to medicines advocate at Public Citizen.
"Policymakers must reject these efforts to undermine Medicare drug price negotiations," Knievel added. "Instead they should build on the program’s success by providing everyone access to negotiated prices, negotiating lower prices for more drugs sooner, and ensuring drug corporations can no longer rip us off by charging the highest prices in the world for medications."